CA2594214A1 - Compositions pharmaceutiques comprenant de la ghreline non acylee et ses utilisations therapeutiques - Google Patents

Compositions pharmaceutiques comprenant de la ghreline non acylee et ses utilisations therapeutiques Download PDF

Info

Publication number
CA2594214A1
CA2594214A1 CA 2594214 CA2594214A CA2594214A1 CA 2594214 A1 CA2594214 A1 CA 2594214A1 CA 2594214 CA2594214 CA 2594214 CA 2594214 A CA2594214 A CA 2594214A CA 2594214 A1 CA2594214 A1 CA 2594214A1
Authority
CA
Canada
Prior art keywords
ghrelin
cells
insulin
unacylated ghrelin
unacylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2594214
Other languages
English (en)
Inventor
Ezio Ghigo
Aart Jan Van Der Lely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millendo Therapeutics SAS
Original Assignee
Alize Pharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/756,456 external-priority patent/US7666833B2/en
Application filed by Alize Pharma SAS filed Critical Alize Pharma SAS
Publication of CA2594214A1 publication Critical patent/CA2594214A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2594214 2007-05-31 2007-06-20 Compositions pharmaceutiques comprenant de la ghreline non acylee et ses utilisations therapeutiques Abandoned CA2594214A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/756,456 US7666833B2 (en) 2001-12-18 2007-05-31 Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
US11/756,456 2007-05-31

Publications (1)

Publication Number Publication Date
CA2594214A1 true CA2594214A1 (fr) 2008-11-30

Family

ID=40091211

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2594214 Abandoned CA2594214A1 (fr) 2007-05-31 2007-06-20 Compositions pharmaceutiques comprenant de la ghreline non acylee et ses utilisations therapeutiques

Country Status (1)

Country Link
CA (1) CA2594214A1 (fr)

Similar Documents

Publication Publication Date Title
US8071368B2 (en) Methods for promoting growth and survival of insulin-secreting cells
US7485620B2 (en) Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
JP5645339B2 (ja) 摂食行動の修正
JP5792925B2 (ja) 過剰体重を防止または治療するためのオキシンソモジュリン
CA2437940C (fr) Procedes de traitement du diabete sucre
Rabiee et al. Pancreatic polypeptide administration enhances insulin sensitivity and reduces the insulin requirement of patients on insulin pump therapy
US20060084597A2 (en) Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
TW201141511A (en) Pharmaceutical composition for treating a metabolic syndrome
JP2017537068A (ja) グルカゴンおよびｇｌｐ−１受容体のコアゴニスト
US11773150B2 (en) Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors
KR20200057059A (ko) 글루카곤 및 glp-1 수용체의 장기-작용성 공-효능제
WO2001066135A1 (fr) Reduction des lipides seriques
JP2002502369A (ja) 胃腸管上部の機能を強化する方法
CA2470235C (fr) Compositions pharmaceutiques comprenant de la ghreline non acylee et utilisations therapeutiques de ces compositions
KR20200130297A (ko) 비만의 치료 및 체중 관리를 위한 glp-1 조성물
US10842851B2 (en) Relaxin for treating patients afflicted of impaired glucose tolerance
Chakraborti Exenatide: a new promising antidiabetic agent
CA2594214A1 (fr) Compositions pharmaceutiques comprenant de la ghreline non acylee et ses utilisations therapeutiques
US20240091318A1 (en) Combination therapy comprising long acting glp-1/glucagon and npy2 receptor agonists
US20230285514A1 (en) Stapled lactam co-agonists of the glucagon and glp-1 receptors
Kalra et al. GLP-1 analogs: newer molecules, newer uses
Kurkin et al. Physiology and pharmacology of glucagon-like peptide-1 receptor

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20150529